Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

Innovation in clinical trials: WINTHER trial

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 10.07.19
Views: 98

Prof Razelle Kurzrock - University of California San Diego, San Diego, USA

Prof Razelle Kurzrock speaks to ecancer at the WIN 2019 Symposium in Paris about the WINTHER trial, which incorporates genomics and transcriptomics to match patients with the most effective drugs.

She summarises the main findings achieved from the trial so far, which include the significance of the RNA data collected in both normal and tumour tissue and the ambiguity that exists when matching patients to the most appropriate drug.

Prof Kurzrock also mentions additional studies that stood out to her from the conference.

 

Related videos

follow us

CML Life Banner


Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation